Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455171 | SCV000540229 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588747 | SCV000699752 | benign | not provided | 2017-07-10 | criteria provided, single submitter | clinical testing | Variant summary: The RTEL1 c.3198A>C (p.Gln1066His) variant involves the alteration of a non-conserved nucleotide that 4/4 in silico tools predict a benign outcome. This variant was found in 87362/115752 control chromosomes (33743 homozygotes) at a frequency of 0.7547343, which indicates that the C allele is the major allele found in the general population. In addition, a clinical diagnostic laboratory classified this variant as benign. Therefore, due to the allele frequency observed in the general control population, the variant of interest has been classified as Benign. |
Labcorp Genetics |
RCV001523489 | SCV001733199 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543257 | SCV001761784 | benign | Dyskeratosis congenita, autosomal recessive 5 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001543258 | SCV001761785 | benign | Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000588747 | SCV001864073 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27128385, 23329068) |
Unidad de Genómica Garrahan, |
RCV000455171 | SCV004232951 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied by a panel of primary immunodeficiencies. Number of patients: 85. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000588747 | SCV005314102 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001273632 | SCV001456923 | benign | Dyskeratosis congenita | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000455171 | SCV001927474 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000455171 | SCV001953376 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000455171 | SCV001971222 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome |
RCV000588747 | SCV002074743 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. |